Positive phase II study in the treatment of advanced malignant melanoma with fotemustine

THIOREDOXIN

1985 • 1,885 citations

Thioredoxin and Glutaredoxin Systems

1989 • 1,778 citations

The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase

1990 • 119 citations

Clinical comparison of the nitrosoureas

1975 • 118 citations

Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule.

1987 • 54 citations

Effects of the new nitrosourea derivative, fotemustine, on the glutathione reductase activity in rat tissues in vivo and in isolated rat hepatocytes

1989 • 18 citations

Disposition, pharmacokinetics, and metabolism of 14C-fotemustine in cancer patients

1990 • 14 citations

Sensitivity and resistance in human metastatic melanoma to the new chloroethylnitrosourea anti-tumor drug Fotemustine

1991 • 14 citations

Fotemustin, ein neues Nitroso-Harnstoff-Derivat

1990 • 2 citations